AGL: agilon health, inc. Market Capitalization-to-Revenue Ratio

Corporate company logo of Agilon Health Corp (AGL)

The price-to-sales ratio exhibits current volatility, where 0.30 determines the current magnitude of the metric. Agilon Health (AGL) management is currently grappling with cost forecast inaccuracies in an effort to restore margins. Meanwhile, IT solutions for elderly patients are scaling rapidly. The business strength is based on a value-based approach, allowing physicians to generate profit through therapeutic efficiency rather than service volume.

AGL Agilon Health P/S Multiple (07/04/2022 - 11/13/2026)

agilon health Inc (AGL) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
- market capitalization information:
General company analysis:agilonhealth.com, AGL
Product sample of agilon health, inc.

To select high-quality assets, an investor must compare market capitalization with actual sales volume to exclude overvalued securities. This ratio measures the cost of one dollar of revenue, which, combined with the high implementation cost of Agilon Health (AGL) software and long-term contracts, allows for an assessment of business sustainability via the P/S trajectory.

Competing companies

VEEV (veeva.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple DOCS (Doximity)|Market Capitalization-to-Revenue Ratio HQY|Waystar Inc. - P/S Multiple|Price to Sales CorVel Corp.|PRVA: P/S Multiple|huronconsultinggroup.com (HURN) - P/S Multiple|Price-to-Revenue Ratio Certara|Price-to-Revenue Ratio OMCL|Market Cap to Revenue GDRX (GoodRx Corp)|Market Cap to Sales Volume SDGR|P/S Multiple PHR (Phreesia, Inc.)|Market Capitalization-to-Revenue Ratio OMDA|Evolent Health - P/S Multiple|HSTM - P/S Multiple|DH: P/S Multiple|Price-to-Revenue Multiple Consensus Corp CCSI|Price-to-Revenue Ratio Absci|Price-to-Revenue Ratio SY|P/S Multiple NRC|Price-to-Revenue Coefficient Spok Holdings Inc|OptimizeRx Corp. - Market Cap to Revenue|Market Cap to Sales Volume TBRG (TruBridge Corp)|SLP: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SOPH (SOPHiA GENETICS SA)|Health Catalyst (HCAT) - Price-to-Revenue Ratio|Market Cap to Revenue CareCloud|RSSS (Research Solutions, Inc.) - P/S Multiple|Price to Sales DLH Holdings Corp DLHC|P/S Multiple ONMD|scienture.com - Market Cap to Revenue Ratio|P/S Multiple HCTI (Healthcare Triangle, Inc.)|P/S Multiple iSpecimen Inc ISPC|Bullfrog AI Holdings Inc - P/S Multiple|Price-to-Revenue Multiple SCWorx Inc (WORX)|MSPR: P/S Multiple|ICCT - Price-to-Revenue Coefficient|Price-to-Revenue Ratio TRxADE HEALTH|Price-to-Revenue Ratio ORGS|Price-to-Revenue Ratio R1 RCM Inc. (RCM)|SHCR - Price to Sales|Price-to-Revenue Ratio Streamline Health Solutions STRM|SYRA: Market Cap to Revenue Ratio|AMEH: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio MODN (Model N Inc)|NXGN: P/S Multiple